Dapagliflozin: Innovation in managing heart failure

In an AstraZeneca symposium entitled “Diabetes Respiratory Academy” held on 19 October 2019 at the Dusit Hotel Makati, specialists in the fields of cardiology and research discussed the new updates in the management of patients with type 2 diabetes (T2D) and the promising evidence on the use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in the management of patients with heart failure.